[A Case of Peritoneal Lymphomatosis Diagnosed by Laparoscopic Biopsy]. 2020

Masato Mito, and Hiroyuki Fukunari, and Akemi Watanabe, and Tetsuji Hayashi
Dept. of Surgery, Niigata Prefectural Tokamachi Hospital.

Peritoneal lymphomatosis is an extremely rare presentation of lymphoma. We report a case of peritoneal lymphomatosis diagnosed by laparoscopic biopsy. A 56-year-old female presented to our hospital with a 2-week history of increasing abdominal distension associated with anorexia and generalized weakness. Abdominal CT findings demonstrated extensive disseminated peritoneal disease with marked thickening of the peritoneal surfaces and a large omental cake with large volume ascites. The examination of blood data and cytology of ascites indicated to the diagnosis of malignant lymphoma. She was proceeded to an urgent laparoscopic biopsy for diagnosis and observed the thickening of the peritoneal surfaces and large volume ascites. Pathological and immunohistochemical examination of the omentum revealed that it was diffuse large B-cell lymphoma presented by peritoneal lymphomatosis. The patient started an immediate course of combination chemotherapy consisting of rituximab, cyclophosphamide, doxorubicin vincristine and prednisolone(R-CHOP)and no recurrence has been noted for 5 years and 10 months from first visit. The differential diagnosis for disseminated peritoneal disease is vast. Laparoscopic biopsy was minimally invasive, and useful for an urgent and accurate the diagnosis and the treatment strategy of disseminated peritoneal disease.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D010534 Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. Peritoneal Carcinomatosis,Peritoneal Surface Malignancy,Carcinomatosis, Peritoneal,Malignancy, Peritoneal Surface,Neoplasm, Peritoneal,Peritoneal Carcinomatoses,Peritoneal Neoplasm,Peritoneal Surface Malignancies,Surface Malignancy, Peritoneal
D010535 Laparoscopy A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy. Celioscopy,Laparoscopic Surgical Procedures,Peritoneoscopy,Surgical Procedures, Laparoscopic,Laparoscopic Assisted Surgery,Laparoscopic Surgery,Laparoscopic Surgical Procedure,Procedure, Laparoscopic Surgical,Procedures, Laparoscopic Surgical,Surgery, Laparoscopic,Surgical Procedure, Laparoscopic,Celioscopies,Laparoscopic Assisted Surgeries,Laparoscopic Surgeries,Laparoscopies,Peritoneoscopies,Surgeries, Laparoscopic,Surgeries, Laparoscopic Assisted,Surgery, Laparoscopic Assisted
D010537 Peritoneum A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall. Parietal Peritoneum,Peritoneum, Parietal,Peritoneum, Visceral,Visceral Peritoneum,Parametrium,Parametriums
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody

Related Publications

Masato Mito, and Hiroyuki Fukunari, and Akemi Watanabe, and Tetsuji Hayashi
December 2022, Gan to kagaku ryoho. Cancer & chemotherapy,
Masato Mito, and Hiroyuki Fukunari, and Akemi Watanabe, and Tetsuji Hayashi
August 2014, Gan to kagaku ryoho. Cancer & chemotherapy,
Masato Mito, and Hiroyuki Fukunari, and Akemi Watanabe, and Tetsuji Hayashi
January 2003, Respiration; international review of thoracic diseases,
Masato Mito, and Hiroyuki Fukunari, and Akemi Watanabe, and Tetsuji Hayashi
January 2022, Journal of medical ultrasound,
Masato Mito, and Hiroyuki Fukunari, and Akemi Watanabe, and Tetsuji Hayashi
April 1997, The European respiratory journal,
Masato Mito, and Hiroyuki Fukunari, and Akemi Watanabe, and Tetsuji Hayashi
July 2000, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Masato Mito, and Hiroyuki Fukunari, and Akemi Watanabe, and Tetsuji Hayashi
June 2004, European journal of internal medicine,
Masato Mito, and Hiroyuki Fukunari, and Akemi Watanabe, and Tetsuji Hayashi
January 2022, Hematology, transfusion and cell therapy,
Masato Mito, and Hiroyuki Fukunari, and Akemi Watanabe, and Tetsuji Hayashi
October 2009, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society,
Masato Mito, and Hiroyuki Fukunari, and Akemi Watanabe, and Tetsuji Hayashi
December 1997, Histopathology,
Copied contents to your clipboard!